Strand Therapeutics, a pioneering company founded by visionary biological engineers from the Massachusetts Institute of Technology, has successfully raised $153 million in its latest funding round. This remarkable achievement not only underscores investor confidence in Strand’s innovative approach to mRNA therapeutics but also reinforces the company’s commitment to revolutionizing how treatments are developed and administered. Built on the groundbreaking concept of smart therapies—systems designed to make sophisticated, autonomous decisions—Strand is at the forefront of creating targeted mRNA treatments that promise to enhance safety and efficacy in patient care. By engineering a unique mRNA programming language, the company has established the world’s first platform for mRNA smart therapies, an area that had remained largely untapped by traditional synthetic biology methods. The infusion of funds will empower Strand to further refine its proprietary technology, which uses intricate mRNA-encoded logic circuits to precisely control the location, timing, and intensity of therapeutic protein expression within the body. These circuits are capable of sensing and classifying the distinct mRNA expression signatures of cells, ensuring that therapeutic interventions are both cell-type specific and adaptive to patient needs. Additionally, the funding is poised to accelerate Strand’s efforts in clinical development and expand its research capabilities, ultimately bringing this advanced therapeutic platform one step closer to transforming patient outcomes. With this significant investment, Strand Therapeutics is well-positioned to lead the charge in creating smarter, safer therapies that meet the demands of modern medicine.
Strand Therapeutics Secures $153M Series B to Pioneer Smart mRNA Therapies
Get the full Strand Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Kigen
Kigen is the forerunner in eSIM and iSIM security solutions, built for IoT at scale in the AI era. We simplify cellular IoT adoption for manufacturers by delivering secure-by-design, standards-based solutions that enable global connectivity with confidence. Our technology sets us apart - delivering freedom to choose from 200+ terrestrial and satellite networks, with proven interoperability on leading chipsets and modules. We streamline every step of eSIM and iSIM-enabled product development - from design to volume production and field deployment - reducing risk, time, and costly rework. Mobile IoT Startup of the Year 2024, backed by technology powerhouses Arm, SoftBank Vision Fund 2, and SBI Group. We're the trusted partner for leading global brands in consumer electronics, energy, automotive, logistics, and industrial automation. We enable manufacturers to deploy one globally connected product instead of managing dozens of regional variants. Our solutions provide secure connectivity from factory lines within seconds, transforming how companies approach IoT deployment at scale. Ready to simplify your IoT connectivity challenges? Visit kigen.com or connect with us here to discover how we're building the #FutureofSIM.
$13.5M Unknown
today
SportVot
Every game deserves an audience. Whether it’s a cover drive in Malad, a 3-pointer in Melbourne, or a raid in Ranchi — if it’s not seen, it’s not celebrated. That’s where SportVot comes in. We’re a global sports tech platform built to give every level of sport — from grassroots to elite — the stage it deserves. What we do: Stream matches from community tournaments to international leagues. Power fully remote, hybrid, and automated productions — managed seamlessly through our cloud studio. Help players, teams, and communities turn visibility into recognition and opportunity. The world has noticed — we’re the Winner of SportsPro OTT’s Global Tech Solution of the Year. Because at SportVot, we believe: If you can play it, you should be able to stream it.
$3.5M Unknown
today
Axoft
Developing a seamless bioelectronic interface.
$55.0M Series a
today
Groove Quantum
At Groove quantum, our mission is to enable quantum advantages by realising the most scalable quantum processor, where the scalability is rooted in our semiconductor, germanium qubit platform. With the dedicated and pioneering Groove team, we are sprouting from QuTech in Delft, a world-leading quantum research institute and we are closely connected to the Delft quantum ecosystem.
$18.8M Seed
today
Spiral Hydrogen
Spiral Hydrogen is building next-generation electrolyzers. Based on alkaline electrolyzers, we solve many core problems plaguing current systems. Our electrolyers have no gas bubbles, and achieve efficiencies up to 95%. We use rotation to pump our electrolyte, achiving current densities up to 3 A/cm². In addition, our stack cost is an order magnitude cheaper, due to a simplified stack design and longer lifetime. Our goal is to get the green hydrogen price below fossil hydrogen, unlocking a €250B market for decarbonization and making hydrogen transportation and heating commercially viable. We have validated our technology in lab conditions (TRL 4) and are looking for pilot partners and investors to build our first pilot (TRL 6).
$3.2M Pre-seed
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | %20%2C%20Inc.png&w=3840&q=75) Membrane Technology and Research (MTR) , Inc United States | Series b | $27.0M | today |
| 2 |  Malta Inc United States | Series b | $60.0M | 1d ago |
| 3 |  SPREAD AI Germany | Series b | $30.0M | 1d ago |
| 4 |  Actively AI United States | Series b | $45.0M | 1d ago |
| 5 |  Actively Canada | Series b | $45.0M | 1d ago |